Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP185374.RAUUQ_WT1UXx1prusWrmwjSyqx2XVfN-L1cdI_f3PPVnc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP185374.RAUUQ_WT1UXx1prusWrmwjSyqx2XVfN-L1cdI_f3PPVnc130_assertion type Assertion NP185374.RAUUQ_WT1UXx1prusWrmwjSyqx2XVfN-L1cdI_f3PPVnc130_head.
- NP185374.RAUUQ_WT1UXx1prusWrmwjSyqx2XVfN-L1cdI_f3PPVnc130_assertion description "[Anti-MCSP:TRAIL alone, or in combination with rimcazole, may be of potential value for the treatment of malignant melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP185374.RAUUQ_WT1UXx1prusWrmwjSyqx2XVfN-L1cdI_f3PPVnc130_provenance.
- NP185374.RAUUQ_WT1UXx1prusWrmwjSyqx2XVfN-L1cdI_f3PPVnc130_assertion evidence source_evidence_literature NP185374.RAUUQ_WT1UXx1prusWrmwjSyqx2XVfN-L1cdI_f3PPVnc130_provenance.
- NP185374.RAUUQ_WT1UXx1prusWrmwjSyqx2XVfN-L1cdI_f3PPVnc130_assertion SIO_000772 21092273 NP185374.RAUUQ_WT1UXx1prusWrmwjSyqx2XVfN-L1cdI_f3PPVnc130_provenance.
- NP185374.RAUUQ_WT1UXx1prusWrmwjSyqx2XVfN-L1cdI_f3PPVnc130_assertion wasDerivedFrom befree-20140225 NP185374.RAUUQ_WT1UXx1prusWrmwjSyqx2XVfN-L1cdI_f3PPVnc130_provenance.
- NP185374.RAUUQ_WT1UXx1prusWrmwjSyqx2XVfN-L1cdI_f3PPVnc130_assertion wasGeneratedBy ECO_0000203 NP185374.RAUUQ_WT1UXx1prusWrmwjSyqx2XVfN-L1cdI_f3PPVnc130_provenance.